Epidemiology of severe asthma and international register
Severe asthma (SA) in an asthma that requires therapy with high dose inhaled corticosteroids with a second controller, or oral corticosteroids, to ensure that it does not become "uncontrolled," or that it does not respond to appropriate therapy. Severe asthma has a great impact on quality of life. There is a great heterogeneity of this disease, not only from a clinical point of view, but also from a functional and pathophysiological one. It is really hard to identify specific characteristics that identify this subgroup. Specific registers of SA, both national and international, are really important to describe the epidemiological characteristics of the disease and to analyze the clinical characteristics of the various subgroups of patients. This is an excellent starting point to be able to investigate the characteristics of the disease in detail.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:112 |
---|---|
Enthalten in: |
Minerva medica - 112(2021), 5 vom: 09. Okt., Seite 542-546 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tagliabue, Elena [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adrenal Cortex Hormones |
---|
Anmerkungen: |
Date Completed 03.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.23736/S0026-4806.21.07281-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322396271 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322396271 | ||
003 | DE-627 | ||
005 | 20231225181943.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.23736/S0026-4806.21.07281-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1074.xml |
035 | |a (DE-627)NLM322396271 | ||
035 | |a (NLM)33682397 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tagliabue, Elena |e verfasserin |4 aut | |
245 | 1 | 0 | |a Epidemiology of severe asthma and international register |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.12.2021 | ||
500 | |a Date Revised 14.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Severe asthma (SA) in an asthma that requires therapy with high dose inhaled corticosteroids with a second controller, or oral corticosteroids, to ensure that it does not become "uncontrolled," or that it does not respond to appropriate therapy. Severe asthma has a great impact on quality of life. There is a great heterogeneity of this disease, not only from a clinical point of view, but also from a functional and pathophysiological one. It is really hard to identify specific characteristics that identify this subgroup. Specific registers of SA, both national and international, are really important to describe the epidemiological characteristics of the disease and to analyze the clinical characteristics of the various subgroups of patients. This is an excellent starting point to be able to investigate the characteristics of the disease in detail | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Anti-Asthmatic Agents |2 NLM | |
700 | 1 | |a Trucco, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Braido, Fulvio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Minerva medica |d 1945 |g 112(2021), 5 vom: 09. Okt., Seite 542-546 |w (DE-627)NLM000053686 |x 1827-1669 |7 nnns |
773 | 1 | 8 | |g volume:112 |g year:2021 |g number:5 |g day:09 |g month:10 |g pages:542-546 |
856 | 4 | 0 | |u http://dx.doi.org/10.23736/S0026-4806.21.07281-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 112 |j 2021 |e 5 |b 09 |c 10 |h 542-546 |